Class information for:
Level 2: CANAVAN DISEASE//PROSTATE SPECIFIC MEMBRANE ANTIGEN//PSMA

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
3119 1786 37.0 83%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 3)


ID, lev.
above		 Publications Label for level above
490 20696 CREATINE//MAGNETIC RESONANCE SPECTROSCOPY//LITHIUM

Classes in level below (level 1)


ID, lev. below Publications Label for level below
8432 1184 CANAVAN DISEASE//PROSTATE SPECIFIC MEMBRANE ANTIGEN//PSMA
25271 238 PROSTATE STEM CELL ANTIGEN//PROSTATE STEM CELL ANTIGEN PSCA//PSCA
29726 148 NORPEG//N COPINE//PSGR
31749 119 STEAP4//STAMP2//STEAP
33143 97 NYGGF4//LYRM1//ZBED6

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CANAVAN DISEASE Author keyword 159 83% 5% 89
2 PROSTATE SPECIFIC MEMBRANE ANTIGEN Author keyword 110 61% 6% 116
3 PSMA Author keyword 102 60% 6% 112
4 N ACETYLASPARTYLGLUTAMATE Author keyword 91 78% 3% 60
5 ASPARTOACYLASE Author keyword 87 83% 3% 49
6 GLUTAMATE CARBOXYPEPTIDASE II Author keyword 68 80% 2% 43
7 NAALADASE Author keyword 64 86% 2% 32
8 NAAG Author keyword 50 71% 2% 40
9 PROSTATE STEM CELL ANTIGEN Author keyword 50 76% 2% 35
10 N ACETYLASPARTIC ACID Author keyword 31 82% 1% 18

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 CANAVAN DISEASE 159 83% 5% 89 Search CANAVAN+DISEASE Search CANAVAN+DISEASE
2 PROSTATE SPECIFIC MEMBRANE ANTIGEN 110 61% 6% 116 Search PROSTATE+SPECIFIC+MEMBRANE+ANTIGEN Search PROSTATE+SPECIFIC+MEMBRANE+ANTIGEN
3 PSMA 102 60% 6% 112 Search PSMA Search PSMA
4 N ACETYLASPARTYLGLUTAMATE 91 78% 3% 60 Search N+ACETYLASPARTYLGLUTAMATE Search N+ACETYLASPARTYLGLUTAMATE
5 ASPARTOACYLASE 87 83% 3% 49 Search ASPARTOACYLASE Search ASPARTOACYLASE
6 GLUTAMATE CARBOXYPEPTIDASE II 68 80% 2% 43 Search GLUTAMATE+CARBOXYPEPTIDASE+II Search GLUTAMATE+CARBOXYPEPTIDASE+II
7 NAALADASE 64 86% 2% 32 Search NAALADASE Search NAALADASE
8 NAAG 50 71% 2% 40 Search NAAG Search NAAG
9 PROSTATE STEM CELL ANTIGEN 50 76% 2% 35 Search PROSTATE+STEM+CELL+ANTIGEN Search PROSTATE+STEM+CELL+ANTIGEN
10 N ACETYLASPARTIC ACID 31 82% 1% 18 Search N+ACETYLASPARTIC+ACID Search N+ACETYLASPARTIC+ACID

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 LINKED ACIDIC DIPEPTIDASE 230 88% 6% 109
2 FOLATE HYDROLASE 144 91% 3% 60
3 NAALADASE 130 91% 3% 53
4 ACIDIC DIPEPTIDASE ACTIVITY 116 97% 2% 33
5 ASPARTOACYLASE DEFICIENCY 114 86% 3% 59
6 NAAG 90 88% 2% 43
7 N ACETYLASPARTIC ACIDURIA 74 84% 2% 41
8 GLUTAMATE CARBOXYPEPTIDASE II 69 52% 5% 95
9 ACETYL ASPARTYL GLUTAMATE 66 79% 2% 42
10 ASPARTYL L GLUTAMATE 65 90% 2% 28

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Prostate-specific membrane antigen-based imaging 2013 27 51 76%
N-acetylaspartate in the CNS: From neurodiagnostics to neurobiology 2007 385 328 32%
Genetic factors related to gastric cancer susceptibility identified using a genome-wide association study 2013 30 54 50%
PET Imaging in Prostate Cancer: Focus on Prostate-Specific Membrane Antigen 2013 25 122 52%
The prostate-specific membrane antigen: Lessons and current clinical implications from 20 years of research 2014 5 50 68%
Glutamate Carboxypeptidase II in Diagnosis and Treatment of Neurologic Disorders and Prostate Cancer 2012 23 197 79%
Inflammation Amplifier, a New Paradigm in Cancer Biology 2014 21 27 19%
N-acetylaspartylglutamate: The most abundant peptide neurotransmitter in the mammalian central nervous system 2000 177 96 80%
Targeted systemic therapy of prostate cancer with a monoclonal antibody to prostate-specific membrane antigen 2003 77 20 90%
Targeted Therapies for Prostate Cancer Against the Prostate Specific Membrane Antigen 2009 45 85 74%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 NEUROTRANSLAT DRUG DISCOVERY PROGRAM 6 58% 0.4% 7
2 BASIC ONCOL PATHOL 3 100% 0.2% 3
3 GASTROENTEROL THORAC SURG 3 100% 0.2% 3
4 HLTH SCREENING ENDOSCOPY 3 100% 0.2% 3
5 INTERNAL MONGOLIA MED 3 100% 0.2% 3
6 THORAC SURG RADIOTHER Y 3 100% 0.2% 3
7 NANJING MATERNAL CHILD HLTH HOSP 3 18% 0.8% 14
8 PHARMACEUT THER Y NEUROPHARMACOL 2 29% 0.4% 7
9 GEORGE M OBRIEN UROL 2 44% 0.2% 4
10 UNIT IMMUNOL MICROBIOL ENVIRONM CARCINOGENESI 2 44% 0.2% 4

Related classes at same level (level 2)


Rank Relatedness score Related classes
1 0.0000014825 FENCAMFAMINE//N ACETYL ASPARTATE//N ACETYLASPARTATE
2 0.0000011580 PARALYSIS//PL NEUROL//PLASMALEMMAL REPAIR
3 0.0000011030 CREATINE//MAGNETIC RESONANCE SPECTROSCOPY//ARGININE KINASE
4 0.0000010155 BENIGN PROSTATIC HYPERPLASIA//PROSTATE CANCER//PROSTATE
5 0.0000009563 CD24//NDRG2//NDRG1
6 0.0000008799 RADIOIMMUNOTHERAPY//BISPECIFIC ANTIBODIES//EP CAM
7 0.0000008021 N PHOSPHORYL AMINO ACID//BIOORGAN PHOSPHORUS CHEM//SERYL HISTIDINE DIPEPTIDE
8 0.0000008011 CARNOSINE//ANSERINE//CARNOSINASE
9 0.0000007053 CIRCULATING TUMOR CELLS//DISSEMINATED TUMOR CELLS//UTEROGLOBIN
10 0.0000006656 PROSTATE CANCER//RADICAL PROSTATECTOMY//PROSTATECTOMY